Evidence map›Paper›PMID 32278300›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2020

Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.

Junguo Zhang, Guanwen Lin, Jie Zeng, Jianguo Lin, Junzhang Tian, Guowei Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junguo ZhangCenter for Clinical Epidemiology and Methodology (CCEM), Guangdong Second Provincial General Hospital, Guangzhou, China.
Guanwen LinDepartment of Infection Management, Guangdong Second Provincial General Hospital, Guangzhou, China.
Jie ZengCenter for Clinical Epidemiology and Methodology (CCEM), Guangdong Second Provincial General Hospital, Guangzhou, China.
Jianguo LinP3 Biosafety Level Laboratory, Guangdong Second Provincial General Hospital, Guangzhou, China.
Junzhang TianCenter for Clinical Epidemiology and Methodology (CCEM), Guangdong Second Provincial General Hospital, Guangzhou, China.
Guowei LiCenter for Clinical Epidemiology and Methodology (CCEM), Guangdong Second Provincial General Hospital, Guangzhou, China; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada. Electronic address: lig28@mcmaster.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With lessons learnt from the SARS outbreak in 2003, Guangdong Province is taking the lead in bringing COVID-19 under control by multiple strict regulations in combination with effective healthcare provision.

Indexed as

BetacoronavirusChinaCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2Severe Acute Respiratory SyndromeCOVID-19Guangdong ProvinceSARS-CoV-2

Identifiers

PMID32278300
PMCPMC7194575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.